Human populations differ in disease prevalences and in average values of phenotypes, but the extent to which differences are caused by genetic or environmental factors is unknown for most complex traits. Comparing phenotypic means across populations is confounded by environmental differences and comparisons based on polygenic predictors can lead to biased inference. Family-based analyses of genetically admixed individuals offer a powerful framework for disentangling the direct and associated effects of genetic ancestry on phenotypes. Here, we leverage genetic data from admixed adults in the Mexico City Prospective Study (MCPS) to estimate within-family ancestry effects. We quantified associations between genetic ancestry and 15 complex traits among 52,583 unrelated individuals and in 39,714 relatives across 17,627 families. At the population level, relative to a European ancestry baseline, we estimate an effect of Indigenous American (IAM) ancestry of -1.98 standard deviations (P < 2×10-16) for height and a natural log-odds ratio (lnOR) of 1.73 (95% confidence interval [CI] 1.54-1.92) for type 2 diabetes (T2D, P < 2×10-16), and multiple associations with other traits and ancestries. We estimated a within-family direct effect of IAM of -1.51 standard deviations (P = 1.02×10-8) for height and lnOR of 5.13 (95% CI 2.48-7.78, P = 1.51×10-4) for risk of T2D. These direct effects are supported by between-ancestry differences in polygenic burden and evidence of selection at trait-associated loci. In contrast, we found no evidence for a direct effect of ancestry on educational attainment or other study traits despite large and significant associations at the population level, implying environmental causes or confounding. Overall, this study provides an experimental design to study between- ancestry genetic effects for complex traits and reports significant ancestry differences for height, T2D, and metabolic-related traits in a genetically diverse population from Mexico City.
Competing Interest StatementThe authors have declared no competing interest.
Funding StatementThis work was supported by funding from the Mexican Health Ministry; the National Council for Science and Technology (CONACyT) for Mexico; the Wellcome Trust [058299/Z/99]; Cancer Research UK; the British Heart Foundation [RE/13/1/30181]; and the UK Medical Research Council [MC_UU_00017/2, MR/Z504543/1]. Genotyping was supported through an academic partnership involving the National Autonomous University of Mexico, the University of Oxford, Regeneron Pharmaceuticals, and AstraZeneca. No authors received payment from a pharmaceutical company or other agency for writing this article.
Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval was obtained from the Mexican Ministry of Health, the Mexican National Council for Science and Technology, and the University of Oxford, UK.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data AvailabilityAll data produced in the present study are available upon reasonable request to the authors
Comments (0)